Here we share information about updates to the National Genomic Test Directory and any updates to our lab processes and procedures that may affect how you request tests or receive results.
You can use the filters below to identify specific types of update or updates related to a particular specialism (theme).
All content
Showing 13 results
Rare disease sequencing delays
Service Update on the delays in East GLH Rare Disease Next Generation Sequencing and whole genome sequencing testing service
Cancer directory update (Sept 2023)
The national genomic test directory specifies which genomic tests are commissioned by the NHS in England and the patients who are eligible to access to each test. The directory is regularly updated and clinicians should check the current version of the directory before referring patients.
Rare disease directory update (July 2023)
The national genomic test directory specifies which genomic tests are commissioned by the NHS in England and the patients who are eligible to access to each test. The directory is regularly updated and clinicians should check the current version of the directory before referring patients.
Inherited cancer delays
Delays in East GLH Inherited Cancer Genomic testing service
Familial hypercholesterlaemia delays
Delays in East GLH Familial Hypercholesterolaemia Genomic testing service
Rare disease directory update (June 2023)
The national genomic test directory specifies which genomic tests are commissioned by the NHS in England and the patients who are eligible to access to each test. The directory is regularly updated and clinicians should check the current version of the directory before referring patients.
Rare disease directory update (April 2023)
The national genomic test directory specifies which genomic tests are commissioned by the NHS in England and the patients who are eligible to access to each test. The directory is regularly updated and clinicians should check the current version of the directory before referring patients.
Neurology rare diseases
Change in delivery of Neurology Rare Disease Clinical Indications
Genotyping for 6- mercaptopurine (6-MP) dosing
Haematological malignancy integrated reporting
Inherited cancer service
Haematological malignancy order forms (Cambridge)
Stored samples
Rare Disease Genomic Test Ordering on Stored Samples